|
Volumn 99, Issue 1, 2011, Pages 97-98
|
Ataxia telangiectasia: The consequences of a delayed diagnosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
ANASTROZOLE;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
IMATINIB;
TRASTUZUMAB;
ADULT;
ATAXIA TELANGIECTASIA;
AXILLARY LYMPH NODE;
BRACHIAL PLEXUS NEUROPATHY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CASE REPORT;
CHOREOATHETOSIS;
CHRONIC MYELOID LEUKEMIA;
DELAYED DIAGNOSIS;
EXON;
FEMALE;
HUMAN;
INTRADUCTAL CARCINOMA;
LETTER;
LEUKEMIA REMISSION;
LYMPHEDEMA;
MASTECTOMY;
MOLECULARLY TARGETED THERAPY;
MUTATIONAL ANALYSIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RADIATION DOSE;
RADIOSENSITIVITY;
SKIN FIBROSIS;
SUBCUTANEOUS TISSUE;
ADULT;
ATAXIA TELANGIECTASIA;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
DELAYED DIAGNOSIS;
FATAL OUTCOME;
FEMALE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
RADIATION TOLERANCE;
|
EID: 79954580877
PISSN: 01678140
EISSN: None
Source Type: Journal
DOI: 10.1016/j.radonc.2011.02.007 Document Type: Letter |
Times cited : (11)
|
References (5)
|